Abstract

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2019 - Volume 23, Number 6

Page(s): 488

Download in electronic PDF format for $75
  • Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Page 1

Abstract

A formulation for preparing Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • pregabalin
  • gabapentinoid
  • voltage-dependent calcium channel inhibitor
  • anticonvulsant agent
  • seizure disorder
  • neuropathic pain
  • muscle pain
  • fibromyalgia
  • pain relief

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2019
Pg. 488
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Nov/Dec 2019
Pg. 486
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2010
Pg. 200-203
Topical Medications for Orofacial Neuropathic Pain
Author(s): Bramwell Bethany L
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2019
Pg. 496-503
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Author(s): Shakshuki Ayah, Agu Remigius U
Jan/Feb 2002
Pg. 4-6
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance
Author(s): Jones Marty
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 193-199
The Role of Sex Hormones on Fibromyalgia Pain Mediators
Author(s): Bramwell Bethany L
Jan/Feb 2000
Pg. 6-15
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium
Author(s): Jones Marty
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 494
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Author(s): Allen Loyd V Jr
May/Jun 2009
Pg. 182-190
Update on Managing Neuropathic Pain
Author(s): McNulty Jack P, Muller George
Nov/Dec 2016
Pg. 517-520
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Author(s): Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Jan/Feb 2018
Pg. 19-24
Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Author(s): Shawaqfeh Mohammad S, Harrington Catherine
Jul/Aug 2015
Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2014
Pg. 14-19
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Author(s): Zur Eyal